期刊文献+

国产生物可降解涂层雷帕霉素洗脱支架的临床研究 被引量:2

下载PDF
导出
摘要 目的观察国产生物可降解涂层雷帕霉素洗脱支架植入后的有效性和安全性。方法连续观察169例冠心病住院患者病情变化,常规进行冠状动脉造影及支架植入。主要观察术后(14.0±7.4)个月无主要不良心脏事件(MACE)生存率,术后急性、亚急性及晚期迟发支架血栓发生率,以及术后6~12个月冠脉造影随访。结果169例患者214支血管247处病变共植入287枚支架。术后(14.0±7.4)个月无MACE生存率98.8%;可能的亚急性支架血栓发生率0.6%,晚期迟发支架血栓发生率0.6%。术后乱12个月冠状动脉造影随访的支架再狭窄为0。结论国产生物可降解涂层雷帕霉素药物支架用于冠状动脉病变的介入治疗是有效且安全的。
出处 《卫生职业教育》 2008年第19期149-150,共2页 HEALTH VOCATIONAL EDUCATION
  • 相关文献

参考文献8

  • 1Kastrati A, Dibra A, Eberle S, et al. Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials[J]. JAMA., 2005,294(7 ) : 819-25.
  • 2Ardissino D, Cavallini C, Bramueci E, et al. Sirolimus-eluting vs uncoated stents for prevention of restenosls in small coronary arteries: a randomized trial[J]. 2004, 292(22):2727-2734.
  • 3Moses J W,Leon M B,Popma J J,et al. Sirolimus-elutiag stents versus standard stents in patients with stenosis in a native coronary artery [J]. N Engl J Med, 2003,349(14) : 1315-1323.
  • 4Lafont A. The Cypher stent: no longer efficacious at three months in the porcine model?[J]. Cardiovase Res,2004,63 (4) : 575-576.
  • 5Fattori R, Piva T. Drug-eluting stents in vascular intervention [J]. Lancet, 2003,361 ( 9353 ): 247-249.
  • 6Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious[J]. Circulation, 2004,109(6) :701-705.
  • 7郑金刚,高润霖,程树军,王春宁,钱杰,阮英茆,王清峙,袁晋青,孟亮,乔树宾,陈纪林.可降解雷帕霉素洗脱支架对猪冠状动脉支架置入术后内膜增生的影响[J].中国循环杂志,2004,19(3):190-193. 被引量:9
  • 8韩雅玲,王守力,荆全民,等.爱克赛尔可降解涂层西罗莫司洗脱支架多中心注册临床研究(CREATE)初步结果[J].中国介入心脏病学杂志,2007,15(4):27-30.

二级参考文献14

  • 1Albiero R,Nishida T,Adamian M,et al.Edge restenosis after implantation of high activity (32)P radioactive beta-emitting stents.Circulation,2000,101:2454-2457.
  • 2Costa MA,Sabat M,van der Giessen WJ,et al.Late coronary occlusion after intracoronary brachytherapy.Circulation,1999,100:789-792.
  • 3Suzuki T,Kopia G,Hayashi S,et al.Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model.Circulation,2001,104:1188-1193.
  • 4Sousa JE,Costa MA,Abizaid A,et al.Lack of noeintimal proliferation after implantation of sirolimus-coated stents in human coronary arteries.Circulation,2001,103 :192-195.
  • 5Tamai H,Igaki K,Kyo E,et al.Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans.Circulation,2000,102:399-404.
  • 6Buergler JM,Tio FO,Schulz DG,et al.Use of Nitro-oxide-eluting polymer-coated coronary stents for prevention of restenosis in pigs.Coron Artery Dis,2000,11: 351 -357.
  • 7Mohacsi PJ,Tuller D,Hulliger B,et al.Different inhibitory effect of immunosupressive drugs on human and rat aortic smooth muscle and endothelial cell proliferation stimulated by platelet-derived growth factor or endothelial cell groth factor.J Heart Loung
  • 8Gallo R,Padurean A ,Jayaraman T,et al.Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle.Circulation,1999,99:2164-2170.
  • 9Lincoff AM,Furst JG,Ellis SG,et al.Sustained local delivery of dexamethasone by a novel intravascular eluting stent to prevent restenosis in the porcine coronary injury model.J Am Coll Cardiol,1997,29: 808-816
  • 10Sousa JE,Costa MA,Sousa AG,et al.Two-year angiographic and intravascular untrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries.Circulation,2003,107:381-383.

共引文献9

同被引文献22

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部